MedTech Regulatory Compliance Expansion
LexisNexis Reed Tech
Regulatory compliance and product data management solutions for medical device manufacturers and pharmaceutical labelers
Did you know? Reed Tech has expanded services for MedTech companies and can become a full-service regulatory advisory bench for your team. See the informational links below and don't hesitate to contact us with questions.?
We recently attended conferences; RAPS EURO in Berlin and MedTech Summit in Brussels. Industry speakers repeatedly emphasized the importance of keeping diligent in monitoring emerging market requirements, product data prep, and taking advantage of opportunities for test submissions of data to EUDAMED. Speaking of conferences, we hope to see you at RAPS Convergence, coming up September 17-19 in Long Beach, CA. Let us know if you'd like to schedule an in-person consultation at the event.?
If you have questions about planning and strategy or just need help with regulatory matters in preparing for UDI submissions to global health authorities, please feel free to contact us via email at [email protected].?
Reed Tech expands regulatory advisory services
Reed Tech is expanding services to help companies develop, implement and remediate UDI systems. If any of the items on this list are not clearly defined for your team, we may be able to help.
A key takeaway from our recent webinars and conference attendance continues to be:?Keep the momentum going for preparing for EUDAMED requirements!
Consider how we can play a greater role in your regulatory submission strategies with expanded capabilities. ?Contact Us
EUDAMED-Now or Later?
Take a deep dive into the EU Roll-Out Amendment with a quick background, timing effects and ways to look at UDI submission strategy. The key item: Plan for the future and keep momentum going on staging product data.?Learn more
Reed Tech can be your US Agent
领英推荐
For foreign companies needing an FDA point of contact, we can serve as a US-based extension of your team. Contact us to learn more via email: [email protected]?Learn more
ICYMI Webinars & Recordings
Hear a concise update on the regulatory framework in China and next topics to monitor. Cisema is China CRO with a wide range of services.
We hosted an insightful session on preparing for NB audits and first-hand advice on navigating the latest updates with the EUDAMED amendment approval. Key takeaway: Don't let up on the momentum for data preparation, testing and submission opportunities.?
Questions? Ask the Experts
If your team has questions about regulatory advisory services, health authority requirements, device classes, Unique Device Identification (UDI) data attributes, or related topics, get in touch! Our experts are happy to help.
Contact us: +1-215-557-3010 | Email us: [email protected]